Status | Study |
Completed |
Study Name: Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients Condition: Hepatitis B, Chronic Date: 2011-04-15 |
Completed |
Study Name: Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2011-03-08 Interventions: Drug: Peginterferon alfa-2a Peginterferon alfa-2a at 180 ug weekly for 24 weeks |
Completed |
Study Name: An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) Condition: Hepatitis B, Chronic Date: 2010-09-17 Interventions: Drug: Adefor dipivoxil All enrolled subjects were enrolled to adefovir dipivoxil arm. |
Completed |
Study Name: Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir Condition: Hepatitis B, Chronic Date: 2009-12-01 Interventions: Drug: Adefovir Adefovir dipivo |
Completed |
Study Name: A Study to Assess DV-601 in Subjects With Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2009-11-30 Interventions: Drug: DV-601 Six injections of |
Completed |
Study Name: Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2009-06-15 Interventions: Drug: Entecavir and peginterferon alfa-2a |
Completed |
Study Name: Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2009-06-08 Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks) |
Completed |
Study Name: Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2009-03-11 Interventions: Drug: interferon α plus nucleoside analogue |
Completed |
Study Name: Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2008-03-26 Interventions: Drug: Telbivudine 600 mg/day, oral telbivudine for 52 weeks |
Completed |
Study Name: A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) Condition: Hepatitis B, Chronic Date: 2008-03-18 Interventions: Drug: Tenofovir All patients receive 600 mg/day, oral telbivudine for 24 weeks. Patients with non-detect |